Real‐World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated Before the Era of Anti‐<scp>CD38</scp> Antibodies: The <scp>EMMY</scp> Cohort From 2017 to 2020
The 2017-2020 period was marked by the expansion of R use in both NDMM ASCT and NTE patients.
Authors
- Karim Belhadj Merzoug
- Laurence Sanhès (ORCID: https://orcid.org/0000-0003-1207-7665)
- Driss Chaoui
- Morten Salomo (ORCID: https://orcid.org/0000-0002-1660-1607)
- Arnaud Jaccard (ORCID: https://orcid.org/0000-0001-7091-8253)
- Ronan Garlantézec (ORCID: https://orcid.org/0000-0001-7420-6341)
- Lionel Karlin (ORCID: https://orcid.org/0000-0002-1185-4488)
- Caroline Jacquet
- Nathalie Texier (ORCID: https://orcid.org/0000-0003-3749-254X)
- Cécile Sonntag (ORCID: https://orcid.org/0009-0001-1616-2501)
- Hervé Avet‐Loiseau (ORCID: https://orcid.org/0000-0002-3050-0140)
- Arthur Bobin (ORCID: https://orcid.org/0000-0002-8416-391X)
- Margaret Macro (ORCID: https://orcid.org/0000-0002-0460-0658)
- Laure Vincent (ORCID: https://orcid.org/0000-0001-5904-1286)
- Thomas Chalopin (ORCID: https://orcid.org/0000-0002-9833-3115)
- Bruno Royer (ORCID: https://orcid.org/0000-0002-8649-7008)
- Zakaria Maarouf
- Chanaz Louni
- Aurore Perrot (ORCID: https://orcid.org/0000-0003-0131-8689)
- Cyrille Hulin (ORCID: https://orcid.org/0000-0002-3749-5161)
- Laurent Frenzel (ORCID: https://orcid.org/0000-0002-6085-2163)
- Mohamad Mohty (ORCID: https://orcid.org/0000-0001-8536-7781)
- Philippe Moreau (ORCID: https://orcid.org/0000-0003-1780-8746)
- D. Caillot
- Olivier Decaux (ORCID: https://orcid.org/0000-0003-2361-9669)
Institutions
- Université de Tours (FR)
- Université Toulouse III - Paul Sabatier (FR)
- Université Fédérale de Toulouse Midi-Pyrénées (FR)
- Université de Montpellier (FR)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Centre Hospitalier Universitaire de Nantes (FR)
- Centre Hospitalier Universitaire Henri-Mondor (FR)
- Centre Hospitalier Universitaire de Toulouse (FR)
- Sorbonne Université (FR)
- Centre Hospitalier de Perpignan (FR)
- Centre Hospitalier Universitaire de Montpellier (FR)
- Centre Hospitalier Universitaire de Tours (FR)
- Institut universitaire du cancer de Toulouse Oncopole (FR)
- Hospices Civils de Lyon (FR)
- Hôpital Saint-Antoine (FR)
- Amyloidosis Foundation (US)
- Centre Hospitalier Universitaire de Poitiers (FR)
- Centre Hospitalier Universitaire de Caen Normandie (FR)
- CHU Dijon Bourgogne (FR)
- Centre Hospitalier Universitaire de Limoges (FR)
- Centre Hospitalier Victor Dupouy (FR)
- Hôpital Saint-Louis (FR)
- Centre Hospitalier Universitaire de Rennes (FR)
- Hôpital d'Hautepierre (FR)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1002/cam4.70619
- Citations
- 1
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.77
Funders
- Bristol-Myers Squibb Foundation
- Amgen
- Pfizer
- Sanofi
- GlaxoSmithKline foundation
- Takeda Oncology